Results for the substance pegaspargase

Pegaspargase is an antineoplastic agent used in the treatment of acute lymphoblastic leukemia (ALL). It works by degrading asparagine, an amino acid essential for the growth of leukemic cells, thereby inhibiting their proliferation.

The medication is administered intravenously or intramuscularly, as directed by a doctor, usually as part of a combination chemotherapy regimen. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.

Patients should be aware of potential side effects, such as allergic reactions, pancreatitis, or coagulation disorders. It is important to inform the doctor of any unusual symptoms.

Common side effects include allergic reactions, elevated liver enzymes, and coagulation disorders. In rare cases, severe reactions such as acute pancreatitis or thrombosis may occur. Patients should be informed of these risks before use.